科兴新冠疫苗完成基础免疫后感染风险随时间变化:检测阴性病例对照研究
在巴西圣保罗州≥18岁完成两剂科兴疫苗接种的成年人中,采用检测阴性病例对照设计,发现完成基础免疫后随时间推移症状性新冠感染的调整比值比升高;65岁及以上人群在完成基础免疫三个月后,中重症新冠结局风险显著增加。
要点
- 完成科兴疫苗基础免疫后,症状性新冠感染的调整比值比随时间推移升高。
- 65岁及以上人群完成基础免疫三个月后,中重症新冠结局风险显著增加。
- 研究结果为在该类人群中实施疫苗加强针提供了支持性证据。
核心结论
- 完成科兴疫苗基础免疫后,随时间推移症状性新冠感染和新冠相关住院或死亡的调整比值比升高。
- 65岁及以上人群完成基础免疫三个月后,中重症新冠结局风险显著增加。
研究设计与样本
- 检测阴性病例对照研究,纳入巴西圣保罗州≥18岁完成两剂科兴疫苗且接种前无实验室确诊SARS-CoV-2感染的居民。
- 病例与检测阴性对照按年龄(5岁组)、居住城市、医务人员身份和RT-PCR检测流行病学周进行匹配。
- 从202 741名符合条件者中,纳入52 170例症状性新冠病例和69 115名有新冠症状的检测阴性对照,形成43 257个匹配组。
主要发现
- 症状性新冠的调整比值比随完成接种系列后时间延长而升高,年轻人和医务人员中升高幅度更大,但敏感性分析提示部分归因于偏倚。
- 与完成系列后14-41天相比,新冠相关住院或死亡的调整比值比在70-97天为1.25(95%CI 1.04-1.51),从182天起升至1.94(95%CI 1.41-2.67)。
临床怎么用
- 对完成科兴疫苗基础免疫的65岁及以上人群,可考虑实施疫苗加强针以降低中重症新冠风险。
- 评估疫苗保护持久性时,研究设计应关注并分析常见偏倚。
局限性
- 年轻人和医务人员中比值比升高幅度更大,敏感性分析提示部分可能归因于偏倚。
- 研究仅纳入科兴疫苗,结论外推至其他疫苗需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To estimate the change in odds of covid-19 over time following primary series completion of the inactivated whole virus vaccine CoronaVac (Sinovac Biotech) in São Paulo State, Brazil. DESIGN: Test negative case-control study. SETTING: Community testing for covid-19 in São Paulo State, Brazil. PARTICIPANTS: Adults aged ≥18 years who were residents of São Paulo state, had received two doses of CoronaVac, did not have a laboratory confirmed SARS-CoV-2 infection before vaccination, and underwent reverse transcription polymerase chain reaction (RT-PCR) testing for SARS-CoV-2 from 17 January to 14 December 2021. Cases were matched to test negative controls by age (in 5 year bands), municipality of residence, healthcare worker status, and epidemiological week of RT-PCR test. MAIN OUTCOME MEASURES: RT-PCR confirmed symptomatic covid-19 and associated hospital admissions and deaths. Conditional logistic regression was adjusted for sex, number of covid-19 associated comorbidities, race, and previous acute respiratory illness. RESULTS: From 202 741 eligible people, 52 170 cases with symptomatic covid-19 and 69 115 test negative controls with covid-19 symptoms were formed into 43 257 matched sets. Adjusted odds ratios of symptomatic covid-19 increased with time since completion of the vaccination series. The increase in odds was greater in younger people and among healthcare workers, although sensitivity analyses suggested that this was in part due to bias. In addition, the adjusted odds ratios of covid-19 related hospital admission or death significantly increased with time compared with the odds 14-41 days after series completion: from 1.25 (95% confidence interval 1.04 to 1.51) at 70-97 days up to 1.94 (1.41 to 2.67) from 182 days onwards. CONCLUSIONS: Significant increases in the risk of moderate and severe covid-19 outcomes occurred three months after primary vaccination with CoronaVac among people aged 65 and older. These findings provide supportive evidence for the implementation of vaccine boosters in these populations who received this inactivated vaccine. Studies of waning should include analyses designed to uncover common biases.
引用
- Hitchings MDT, Ranzani OT, Lind ML, et al. Change in covid-19 risk over time following vaccination with CoronaVac: test negative case-control study. BMJ. 2022. PMID: 35697361. doi:10.1136/bmj-2022-070102
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。